홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

4-Methylmorpholine → HCID 117859816, 화합물

HRID 1486338
인쇄

반응식

HRID 1486338 반응식
[NH2:1][CH2:2][C:3]1([NH:6]C(=O)OC(C)(C)C)[CH2:5][CH2:4]1.[F:14][C:15]1[CH:36]=[CH:35][CH:34]=[C:33]([F:37])[C:16]=1[CH2:17][O:18][C:19]1[N:24]2[N:25]=[C:26]([CH3:31])[C:27]([C:28](O)=[O:29])=[C:23]2[CH:22]=[C:21]([CH3:32])[CH:20]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CN1CCOCC1>CN(C=O)C.ClCCl>[NH2:6][C:3]1([CH2:2][NH:1][C:28]([C:27]2[C:26]([CH3:31])=[N:25][N:24]3[C:19]([O:18][CH2:17][C:16]4[C:33]([F:37])=[CH:34][CH:35]=[CH:36][C:15]=4[F:14])=[CH:20][C:21]([CH3:32])=[CH:22][C:23]=23)=[O:29])[CH2:4][CH2:5]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 79724-MethylmorpholineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 46864104tert-butyl N-(1-(aminomethyl)cyclopropyl)carbamateHCID 117859510HCID 117859510, 화합물

생성물 1

HCID 117859816HCID 117859816, 화합물

시약·촉매·용매 1

HCID 22350042dichloromethane N,N-dimethylformamide용매2회

실험 절차

20.5 mg (0.11 mmol) of tert-butyl [1-(aminomethyl)cyclopropyl]carbamate were initially charged in a 96-well deep well multititre plate. A solution of 33.2 mg (0.1 mmol) of 7-[(2,6-difluorobenzyl)oxy]-2,5-dimethylpyrazolo[1,5-a]pyridine-3-carboxylic acid from Example 4A in 0.4 ml of DMF/dichloromethane (1:1, v/v) and a solution of 49.4 mg (0.13 mol) of HATU in 0.4 ml of DMF/dichloromethane (1:1, v/v) were added successively. After adding 20.2 mg (0.20 mmol) of 4-methylmorpholine, the mixture was shaken at RT overnight. Subsequently, the mixture was heated to 60° C. and shaken at this temperature for 7 h. Then the solvent was evaporated off completely. The residue was admixed with 0.6 ml of TFA and shaken at room temperature overnight. Then the mixture was concentrated fully, the residue was dissolved in 0.8 ml of DMF and filtered, and the target compound was isolated from the filtrate by preparative LC-MS (Method 9). The product-containing fractions were concentrated under reduced pressure using a centrifugal dryer. The residue of each product fraction was dissolved in 0.6 ml of DMSO. These were combined and finally freed of the solvent in a centrifugal dryer. 0.5 mg (1.3% of theory) of the title compound were obtained.

후처리

  1. temperatureSubsequently, the mixture was heated to 60° C.
  2. stirringshaken at this temperature for 7 h
  3. customThen the solvent was evaporated off completely
  4. stirringshaken at room temperature overnight
  5. concentrationThen the mixture was concentrated fully
  6. dissolutionthe residue was dissolved in 0.8 ml of DMF
  7. filtrationfiltered
  8. customthe target compound was isolated from the filtrate by preparative LC-MS (Method 9)
  9. concentrationThe product-containing fractions were concentrated under reduced pressure
  10. dissolutionThe residue of each product fraction was dissolved in 0.6 ml of DMSO

출처 및 근거

ORD 기록
ord-ece736e7fb514c609a4797fc2bdaa26c
출처 데이터셋
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09422285B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트